Zienab E. Eldin
Impact in
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- MXene and MAX Phase Materials 7
- Layered Double Hydroxides Synthesis and Applications 6
-
- Nanoplatforms for cancer theranostics 10
- Co-authors
- Hanan M. Alharbi (5 shared papers)Ahmed A. G. El‐Shahawy (8 shared papers)Abo Bakr Abdel Shakor (4 shared papers)Haifa E. Alfassam (5 shared papers)Mohamed Abd El–Aal (3 shared papers)Mohammed Al‐Zharani (7 shared papers)Nawal Madkhali (2 shared papers)Ahmed A. Farghali (5 shared papers)
- Journals
- Scientific Reports (5 papers)International Journal of Biological Macromolecules (4 papers)RSC Advances (3 papers)Journal of Drug Delivery Science and Technology (3 papers)ACS Omega (2 papers)
- Partner nations
- EgyptSaudi ArabiaBangladesh
In The Last Decade
Zienab E. Eldin
44 papers receiving 381 citations
Peers
Comparison fields: 5 of 78
- Drug Discovery 1
- Biomaterials 60
- Molecular Medicine 21
- Pharmaceutical Science 16
- Biochemistry 13
Countries citing papers authored by Zienab E. Eldin
This map shows the geographic impact of Zienab E. Eldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zienab E. Eldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zienab E. Eldin more than expected).
Fields of papers citing papers by Zienab E. Eldin
This network shows the impact of papers produced by Zienab E. Eldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zienab E. Eldin. The network helps show where Zienab E. Eldin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zienab E. Eldin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 28 | |
| 2 | 2021 | 27 | |
| 3 | 2023 | 20 | |
| 4 | 2022 | 15 | |
| 5 | 2024 | 15 | |
| 6 | 2022 | 15 | |
| 7 | 2023 | 14 | |
| 8 | 2024 | 14 | |
| 9 | 2024 | 13 | |
| 10 | 2024 | 13 | |
| 11 | 2024 | 13 | |
| 12 | 2024 | 13 | |
| 13 | 2025 | 12 | |
| 14 | 2025 | 12 | |
| 15 | 2024 | 11 | |
| 16 | 2024 | 11 | |
| 17 | 2025 | 10 | |
| 18 | 2024 | 10 | |
| 19 | 2025 | 10 | |
| 20 | 2024 | 8 |
About Zienab E. Eldin
Zienab E. Eldin is a scholar working on Materials Chemistry, Biomedical Engineering, Molecular Biology, Organic Chemistry and Water Science and Technology, having authored 50 papers that have together received 384 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), MXene and MAX Phase Materials (7 papers), Layered Double Hydroxides Synthesis and Applications (6 papers), Adsorption and biosorption for pollutant removal (5 papers), Nanomaterials for catalytic reactions (4 papers), Metal-Organic Frameworks: Synthesis and Applications (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Bee Products Chemical Analysis (3 papers). The work is most often cited by research in Drug Discovery (1 citation), Biomaterials (60 citations), Molecular Medicine (21 citations), Pharmaceutical Science (16 citations) and Biochemistry (13 citations). Zienab E. Eldin has collaborated with scholars based in Egypt, Saudi Arabia and Bangladesh. Frequent co-authors include Hanan M. Alharbi, Ahmed A. G. El‐Shahawy, Abo Bakr Abdel Shakor, Haifa E. Alfassam, Mohamed Abd El–Aal, Mohammed Al‐Zharani, Nawal Madkhali, Ahmed A. Farghali, Fahd A. Nasr and Ahmad M. Saeedi. Their work appears in journals such as Scientific Reports, International Journal of Biological Macromolecules, RSC Advances, Journal of Drug Delivery Science and Technology and ACS Omega.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.